DexCom, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2025: USD 4.15 B

DexCom, Inc. Revenue is USD 4.15 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 9.11% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • DexCom, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 3.80 B, a 25.78% change year over year.
  • DexCom, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 3.02 B, a 17.50% change year over year.
  • DexCom, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 2.57 B, a 26.93% change year over year.
  • DexCom, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 2.03 B, a 26.62% change year over year.
Key Data
Date Revenue Revenue Gross Profit Operating Income